These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 10736251

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Amniotic fluid levels of CA 19.9 and CA 15.3 in normal and Down's syndrome pregnancies.
    Noci I, Borri P, Biagiotti R, Cariati E, Branconi F, Torricelli F, Cappelli G, D'Agata A.
    J Perinat Med; 1995; 23(3):237-41. PubMed ID: 8568617
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Placental and maternal serum inhibin-A and activin-A levels in Down's syndrome pregnancies.
    Dalgliesh GL, Aitken DA, Lyall F, Howatson AG, Connor JM.
    Placenta; 2001; 22(2-3):227-34. PubMed ID: 11170828
    [Abstract] [Full Text] [Related]

  • 6. Heat-stable and immunoreactive placental alkaline phosphatase in maternal serum from Down's syndrome and trisomy 18 pregnancies.
    Aitken DA, Syvertsen BS, Crossley JA, Berry E, Connor JM.
    Prenat Diagn; 1996 Nov; 16(11):1051-4. PubMed ID: 8953641
    [Abstract] [Full Text] [Related]

  • 7. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy].
    Lesin J, Skrablin S, Durić K, Suchanek E, Muzinić D, Kalafatić D, Kuvacić I, Zlopasa G, Plavec A.
    Lijec Vjesn; 2003 Nov; 125(3-4):55-60. PubMed ID: 12899094
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
    Morssink LP, Sikkema-Raddatz B, Beekhuis JR, De Wolf BT, Mantingh A.
    Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
    [Abstract] [Full Text] [Related]

  • 12. Maternal serum markers for Down's syndrome pregnancies.
    Chew S, Anandakumar C, Ratnam SS.
    Singapore Med J; 1995 Aug; 36(4):417-23. PubMed ID: 8919160
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: implications for screening for Down's syndrome.
    Wald NJ, Cuckle HS, Densem JW, Stone RB.
    Br J Obstet Gynaecol; 1992 Jan; 99(1):51-3. PubMed ID: 1372176
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Biochemical markers of trisomy 21 in amniotic fluid.
    Spencer K, Muller F, Aitken DA.
    Prenat Diagn; 1997 Jan; 17(1):31-7. PubMed ID: 9021826
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Second-trimester unconjugated oestriol levels in maternal serum from chromosomally abnormal pregnancies using an optimized assay.
    Crossley JA, Aitken DA, Connor JM.
    Prenat Diagn; 1993 Apr; 13(4):271-80. PubMed ID: 7685092
    [Abstract] [Full Text] [Related]

  • 19. Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancy.
    Lambert-Messerlian GM, Canick JA, Palomaki GE, Schneyer AL.
    J Med Screen; 1996 Apr; 3(2):58-62. PubMed ID: 8849760
    [Abstract] [Full Text] [Related]

  • 20. The prediction of adverse pregnancy outcome using low unconjugated estriol in the second trimester of pregnancy without risk of Down's syndrome.
    Kim SY, Kim SK, Lee JS, Kim IK, Lee K.
    Yonsei Med J; 2000 Apr; 41(2):226-9. PubMed ID: 10817024
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.